Sp1-mediated transcription of the Werner Helicase gene is modulated by Rb and p53

Molecular and Cellular Biology

Volumn 18, Issue 11, 1998, Pages 6191-6200

  Yamabe, Yukako ^a   Shimamoto, Akira ^a   Goto, Makoto ^b   Yokota, Jun ^c   Sugawara, Minoru ^a   Furuichi, Yasuhiro ^a  

^a AGENE Research Institute   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; HELICASE; NUCLEAR PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SENESCENCE; TRANSCRIPTION REGULATION; WERNER SYNDROME;

EID: 0031792774     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.11.6191     Document Type: Article

References (49)

1. Agoff, S. N., J. Hou, D. I. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Berk, A. J., and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell 12:721-732.
4. Borellini, F., and R. I. Glazer. 1993. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem. 268:7923-7928.
5. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
6. Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y. H. Fu, S. Grunwald, and R. Chiu. 1994. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14:4380-4389.
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
9. Epstein, C. J., G. M. Martin, A. L. Schultz, and A. G. Motulsky. 1966. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45:177-221.
10. Faragher, R. G., I. R. Kill, J. A. Hunter, F. M. Pope, C. Tannock, and S. Shall. 1993. The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc. Natl. Acad. Sci. USA 90:12030-12034.
11. Farmer, G., J. Colgan, Y. Nakatani, J. L. Manley, and C. Prives. 1996. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol. Cell. Biol. 16:4295-4304.
12. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417.
13. Goto, M., O. Imamura, J. Kuromitsu, T. Matsumoto, Y. Yamabe, Y. Tokutake, N. Suzuki, B. Mason, D. Drayna, M. Sugawara, M. Sugimoto, and Y. Furuichi. 1997. Analysis of helicase gene mutations in Japanese Werner's syndrome patients. Hum. Genet. 99:191-193.
14. Goto, M., R. W. Miller, Y. Ishikawa, and H. Sugano. 1996. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol. Biomarkers Prev. 5:239-246.
15. Goto, M., K. Tanimoto, Y. Horiuchi, and T. Sasazuki. 1981. Family analysis of Werner's syndrome: a survey of 42 Japanese families with a review of the literature. Clin. Genet. 19:8-15.
16. Guarente, L. 1996. Do changes in chromosomes cause aging? Cell 86:9-12.
17. Haffner, R., and M. Oren. 1995. Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5:84-90.
18. Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J.-C. Biscan, A. Valent, A. Minty, P. Chalon, J.-M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
19. Kim, S. J., H. D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052-3056.
20. Kim, S. J., S. Wagner, F. Liu, M. A. O'Reilly, P. D. Robbins, and M. R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358:331-334.
21. Kley, N., R. Y. Chung, S. Fay, J. P. Loeffler, and B. R. Seizinger. 1992. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res. 20:4083-4087.
22. Kulju, K. S., and. J. M. Lehman. 1995. Increased p53 protein associated with aging in human diploid fibroblasts. Exp. Cell Res. 217:336-345.
23. Martin, G. M. 1978. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects 14:5-39.
24. Mastrangelo, I. A., A. J. Courey, J. S. Wall, S. P. Jackson, and P. V. Hough. 1991. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. USA 88:5670-5674.
25. Matsumoto, T., O. Imamura, Y. Yamabe, J. Kuromitsu, Y. Tokutake, A. Shimamoto, N. Suzuki, M. Satoh, S. Kitao, K. Ichikawa, H. Kataoka, K. Sugawara, W. Thomas, B. Mason, Z. Tsuchihashi, D. Drayna, M. Sugawara, M. Sugimoto, Y. Furuichi, and M. Goto. 1997. Mutation and haplotype analyses of the Werner's syndrome gene based on its genomic structure: genetic epidemiology in the Japanese population. Hum. Genet. 100:123-130.
26. Matsumoto, T., A. Shimamoto, M. Goto, and Y. Furuichi. 1997. Impaired nuclear localization of defective DNA helicases in Werner's syndrome. Nat. Genet. 16:335-336.
27. Monnat, R. J., Jr. 1992. Werner syndrome: molecular genetics and mechanistic hypotheses. Exp. Gerontol. 27:447-453.
28. O'Brien, C. A., and S. C. Manolagas. 1997. Isolation and characterization of the human gp130 promoter. Regulation by STATS. J. Biol. Chem. 272: 15003-15010.
29. Ookawa, K., S. Tsuchida, J. Adachi, and J. Yokota. 1997. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line. Oncogene 14:1389-1396.
30. Robbins, P. D., J. M. Horowitz, and R. C. Mulligan. 1990. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 346:668-671.
31. Runger, T. M., C. Bauer, B. Dekant, K. Moller, P. Sobotta, C. Czerny, M. Poot, and G. M. Martin. 1994. Hypermutable ligation of plasmid DNA ends in cells from patients with Werner syndrome. J. Invest. Dermatol. 102:45-48.
32. Salk, D., E. Bryant, H. Hoehn, P. Johnston, and G. M. Martin. 1985. Growth characteristics of Werner syndrome cells in vitro. Adv. Exp. Med. Biol. 190:305-311.
33. Schonberg, S., M. F. Niermeijer, D. Bootsma, E. Henderson, and J. German. 1984. Werner's syndrome: proliferation in vitro of clones of cells bearing chromosome translocations. Am. J. Hum. Genet. 36:387-397.
34. Shay, J. W., O. M. Pereira-Smith, and W. E. Wright. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33-39.
35. Shiio, Y., T. Yamamoto, and N. Yamaguchi. 1992. Negative regulation of Rb expression by the p53 gene product. Proc. Natl. Acad. Sci. USA 89:5206-5210.
36. Shimamoto, A., S. Kitao, K. Ichikawa, N. Suzuki, Y. Yamabe, O. Imamura, Y. Tokutake, M. Satoh, T. Matsumoto, J. Kuromitsu, H. Kataoka, K. Sugawara, M. Sugawara, M. Sugimoto, M. Goto, and Y. Furuichi. 1996. A unique human gene that spans over 230 kb in the human chromosome 8p11-12 and codes multiple family proteins sharing RNA-binding motifs. Proc. Natl. Acad. Sci. USA 93:10913-10917.
37. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-158.
38. Smoller, D. A., D. Petrov, and D. L. Hartl. 1991. Characterization of bacteriophage P1 library containing inserts of Drosophila DNA of 75-100 kilobase pairs. Chromosoma 100:487-494.
39. Sugrue, M. M., D. Y. Shin, S. W. Lee, and S. A. Aaronson. 1997. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA 94:9648-9653.
40. Suzuki, N., A. Shimamoto, O. Imamura, J. Kuromitsu, S. Kitao, M. Goto, and Y. Furuichi. 1997. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res. 25:2973-2979.
41. Tahara, H., Y. Tokutake, S. Maeda, H. Kataoka, T. Watanabe, M. Satoh, T. Matsumoto, M. Sugawara, T. Ide, M. Goto, Y. Furuichi, and M. Sugimoto. 1997. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15:1911-1920.
42. Tuteja, N., and R. Tuteja. 1996. DNA helicases: the long unwinding road. Nat. Genet. 13:11-12.
43. Uchida, T., K. Takahashi, K. Tatsuno, U. Dhingra, and J. F. Eliason. 1996. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. Int. J. Cancer 67:892-897.
44. Udvadia, A. J., K. T. Rogers, P. D. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. M. Horowitz. 1993. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB. Proc. Natl. Acad. Sci. USA 90:3265-3269.
45. Wang, Q., G. P. Zambetti, and D. P. Suttle. 1997. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor. Mol. Cell. Biol. 17:389-397.
46. Webster, N. J., J. L. Resnik, D. B. Reichart, B. Strauss, M. Haas, and B. L. Seely. 1996. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res. 56:2781-2788.
47. Yamabe, Y., M. Sugimoto, M. Satoh, N. Suzuki, M. Sugawara, M. Goto, and Y. Furuichi. 1997. Down-regulation of the defective transcripts of the Werner's syndrome gene in the cells of patients. Biochem. Biophys. Res. Commun. 236:151-154.
48. Yu, C. E., J. Oshima, Y. H. Fu, E. M. Wijsman, F. Hisama, R. Alisch, S. Matthews, J. Nakura, T. Miki, S. Ouais, G. M. Martin, J. Mulligan, and G. D. Schellenberg. 1996. Positional cloning of the Werner's syndrome gene. Science 272:258-262.
49. Yu, C. E., J. Oshima, E. M. Wijsman, J. Nakura, T. Miki, C. Piussan, S. Matthews, Y. H. Fu, J. Mulligan, G. M. Martin, and G. D. Schellenberg. 1997. Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am. J. Hum. Genet. 60: 330-341.